[ORGANIZATION]
University of Washington School of Medicine
Featured in 9 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
314 clusters · 1158 sources · last updated
Latest: GLP-1 medications and weight management strategies
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema
Advancements in kidney disease treatment and care models
2 clusters · 6 sources · last updated
Latest: Developments in Chronic Kidney Disease treatment and value-based care
Recent developments in nephrology highlight progress in both therapeutic interventions and healthcare delivery. Clinical trial data presented at ASN Kidney Week 2026 indicate significant efficacy for new treatments. In t
DNA Typewriter and PEtracer map mouse embryo lineages
3 clusters · 9 sources · last updated
Latest: New genome-editing tools trace mouse embryo cell lineages
Researchers from the University of Washington, Dartmouth College, and Sloan Kettering have developed a novel genetic marking technology called ‘DNA Typewriter’ to map the cellular lineage of mouse embryos. The technolo
Research on biological age and early-onset health risks
6 clusters · 30 sources · last updated
Latest: Health studies link mid-life cardiovascular markers and biological age to longevity and cancer risk
Scientific research continues to emphasize biological age as a critical indicator of health risks, distinct from chronological age. Previous studies involving UK Biobank data linked accelerated aging to increased risks o
Also covered in
-
University of Washington study links GLP-1 discontinuation to higher cardiovascular risk
[HEALTH] · 2 sources ·